Per-Göran Gillberg, Ph.D., Prof.

Vice President, Development and Co-Founder

Per-Göran Gillberg has proven expertise and a track record of success in the Swedish pharmaceutical industry, with over 25 years of experience at Pharmacia, Kabi and AstraZeneca. He has industry experience covering drug discovery and development through to marketed products. In particular, he played an instrumental role in the preclinical and clinical development of tolterodine, a marketed treatment for urinary incontinence.

Team members

Ron Cooper

President and Chief Executive Officer

Martha (Muffy) Carter

Chief Regulatory Officer

Jason Duncan

General Counsel

Per-Göran Gillberg, Ph.D., Prof.

Vice President, Development and Co-Founder

Jan Mattsson, Ph.D.

Chief Operating Officer and Co-Founder

Tom Shea

Chief Financial Officer

Paresh Soni, M.D., Ph.D.

Chief Medical Officer

Kristina Torfgård, Ph.D.

Vice President, Global Project Head